Use of Buprenorphine in Managing Cancer Pain and Transition to Survivorship
Clinical Journal of Oncology Nursing · 2025
DOI: 10.1188/25.cjon.361-364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of Oncology Nursing, 2025. Verfasst von Heather J Jackson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Heather J. Jackson. Hauptthemen laut MEDLINE: Buprenorphine, Cancer Pain, Analgesics, Opioid, Pain Management. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The management of cancer-related pain can often be challenging because clinicians must balance comfort with the potential side effects of prescribed treatments. Buprenorphine, a partial mu-opioid receptor agonist, offers a lo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heather J. Jackson.
- Taylor Butler.
- Bethany Raffalovich.
- Karen Hande.
Zitieren
APA
Jackson, H. J., Butler, T., Raffalovich, B., & Hande, K. (2025). Use of Buprenorphine in Managing Cancer Pain and Transition to Survivorship. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/25.cjon.361-364
Vancouver
Jackson HJ, Butler T, Raffalovich B, Hande K. Use of Buprenorphine in Managing Cancer Pain and Transition to Survivorship. Clinical Journal of Oncology Nursing. 2025. doi:10.1188/25.cjon.361-364
BibTeX
@article{Jackson2025,
author = {Jackson, Heather J and Butler, Taylor and Raffalovich, Bethany and Hande, Karen},
title = {Use of Buprenorphine in Managing Cancer Pain and Transition to Survivorship},
journal = {Clinical Journal of Oncology Nursing},
year = {2025},
doi = {10.1188/25.cjon.361-364}
}
EUVIMED